// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Primary neuroendocrine tumors of the liver: Diagnosis, management and survival

C. Delimpalta - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Neuroendocrine tumors

N/A

Predicting early disease recurrence following resection of colorectal liver metastases

S.M. Robinson - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Colorectal liver metastases

N/A

Is there any prognostic relevance of immunoprofiling biliopancreatic adenocarcinomas?

M.A. D'souza - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Liver cancer

N/A

Impact of synchronous versus metachronous colorectal liver metastases (CRLM) on overall survival and recurrence: in patients undergoing liver resection with >4 lesions

N.S. Shah - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Colorectal liver metastases

N/A

Pre-operative measures of systemic inflammation do not predict outcome following resection of colorectal liver metastases

S.M. Robinson - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Colorectal liver metastases

N/A

Survival outcomes following hepatectomy for stage iv colorectal liver metastase A comparison of liver- versus colon-first approach

V.S. Yip - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Colorectal liver metastases

N/A

A comparison of long-term outcomes in patients with colorectal liver metastases undergoing complete(R0) and microscopically incomplete(R1) hepatic resection

J. Skipworth - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Colorectal liver metastases

N/A

Surgical management of renal cell carcinoma metastasis to the liver and pancrea An 11-year single center experience

N.A. Chatzizacharias - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Renal cell carcinoma

N/A

Pancreatico-duodenectomy for non-ampullary duodenal lesion Indications and results

A. Shamali - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The detection of incidental pancreatic pathology on CT: Comparison of an HPB unit and a general hospital

S. McCain - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The predictive ability of timed ‘Up & Go’ in hepato-pancreato-biliary onco-geriatric surgical patients : A multi-center prospective study

M.G. Huisman - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

Laparoscopic versus open distal pancreatectomy: Systematic review and meta-analysis of case matched series

S. Pericleous - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Preoperative biliary intervention is associated with colonisation by multi-resistant organisms in patients undergoing pancreatic surgery

M. Nnaji - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Long-Term Outcomes of Surgical Management of Pancreatic Neuroendocrine Tumors with Synchronous Liver Metastases

D. Tamburrino - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Pancreatic Neuroendocrine Tumors

N/A

Developing robotic HPB surgery: A single centre experience

S.M. Robinson - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Is Pre-Operative CA19-9 measurement predictive of early recurrence following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma?

C.L. Evans - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Pancreas ductal adenocarcinoma

N/A

Superior Mesenteric Artery Resection During Pancreatectomy for Tumour: Pooled Outcome and Survival Analysis

S. Jegatheeswaran - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Calculating risk of pancreatic fistula following pancreaticoduodenectomy: A systematic review

A.E. Vallance - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Can an enhanced recovery program further enhance the benefits of laparoscopic distal pancreatectomy?

B. Jaber - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Laparoscopic radical ‘no-touch’ left pancreatectomy for pancreatic adenocarcinoma: technique and results

T. de Rooij - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Pancreatic cancer

N/A

Copyright © 2026. QuantiNova All rights reserved